BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for the product LIAISON® Borrelia IgG, DiaSorin S.p.A.

Product group In-vitro diagnostics - microbiological products
Reference 07768/14

For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.

Corrective action for the product LIAISON® Borrelia IgG, DiaSorin S.p.A. , Download_VeroeffentlichtAm_EN PDF, 655KB, File does not meet accessibility standards